| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |